Develops medicines for obesity and muscle wasting.
Dec 2025Revenue $590K/yrExpenses $8.34M/yr
No trend
Figures by year
When will PMGC Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $590K and expenses $8.34M.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2025 | $590K | $8.34M | −$7.75M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.